http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#Head
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#assertion
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#provenance
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#pubinfo
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#assertion
http://purl.obolibrary.org/obo/DOID_0060224
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_0060224
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00204
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association
http://www.w3.org/2000/01/rdf-schema#label
maintenance of normal sinus rhythm delay in af afl recurrence dofetilide capsules are indicated for the maintenance of normal sinus rhythm delay in time to recurrence of atrial fibrillation atrial flutter af afl in patients with atrial fibrillation atrial flutter of greater than one week duration who have been converted to normal sinus rhythm because dofetilide can cause life threatening ventricular arrhythmias it should be reserved for patients in whom atrial fibrillation atrial flutter is highly symptomatic in general antiarrhythmic therapy for atrial fibrillation atrial flutter aims to prolong the time in normal sinus rhythm recurrence is expected in some patients see clinical studies conversion of atrial fibrillation flutter dofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm dofetilide capsules have not been shown to be effective in patients with paroxysmal atrial fibrillation
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00204
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#provenance
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#pubinfo
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#sig
http://purl.org/nanopub/x/hasSignature
d/XvXs8aGarSto2UdBRoUBqJqrXg7i59hDSk3XB+cznXNPntvJjdFHo1XTogQkNCaTMLiQq98rTY/+nQONxOUhvwt1mJeyTp3cGa2Vcwf+v9fg5tTX5Dz0M0Cjrz7aRwVKi+uZMAMUS1h3RiPaUL2KkDnem3GaQ72b5pTPLpyF0=
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
http://purl.org/dc/terms/created
2021-06-27T20:12:56.866+02:00
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs